Skip to main content
Equibles
ZOMDF logo

ZOMDF · Zomedica Corp.

Track ZOMDF — free

Use ZOMDF with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about ZOMDF

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$0.09 +0.00 (+0.12%) At close · Aug 24
Market Cap
$84.28M
Shares
979.95M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$0.09 Open$0.09 Day$0.08–0.09 52W close$0.04–0.15 Avg vol 30d648K Short int174K · 0.0% float · 1.0d Short vol16% Last earningsAug 5, 2026 DataJan 2020–Aug 2026 Filing10-Q · Aug 5

Up next

Next earnings call
Oct 31, 2026 Est · unconfirmed · in 10 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
Latest filing: 10-Q
filed Aug 5, 2026

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Neutral Momentum Very Weak Sentiment Bearish Fundamentals Fair Quant / Vol Very High
Market backdrop VIX 15.9 · calm Equity put/call 0.68
Technical
price trend
Neutral
50 / 200-day cross No cross
Price vs 200-day avg −20%
below
Price vs 50-day avg −3%
below
RSI (14) 48
neutral
MACD trend Positive
52-week position 40%
mid-range
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Weak
1-month return −3%
trailing
6-month return −29%
trailing
YTD return −16%
this year
Relative strength −41%
vs S&P · 6-mo
Sentiment
smart money
Bearish
Trend (MA cross) No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow Distributing
-14% holders QoQ · +2 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.02% of float · ▲ +36.8% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
6 holders — mid 3-yr range
Squeeze score 31
low risk · 0–100
Fundamentals
Fair
Gross margin 525%
EPS growth −60%
Y/Y
Free cash flow $-18.2M
Balance sheet $9.0M
net cash
Quant / Vol
risk profile
Very High
Volatility 88%
annualized · 1-yr
Max drawdown −52%
past year
ATR 8.4%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Neutral
1 · 5 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−20% Bearish
Price vs 50-day avg
−3% Neutral
RSI (14)
48 Neutral
MACD trend
Positive Bullish
52-week position
40% Neutral
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross) No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow Distributing
-14% holders QoQ · +2 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.02% of float · ▲ +36.8% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
6 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $0 Now $0 · 40% Range high $0
vs 200-day avg -20% vs 50-day avg -3%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
Adjusted Non-GAAP EBITDA loss non-GAAP $4.7M six months ended June 30, 2026 —
Cash burn improvement $3.2M six months ended June 30, 2026 —
Liquidity $44.1M As of June 30, 2026 —
Non-GAAP EBITDA loss non-GAAP $4.7M six months ended June 30, 2026 —

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Medical Devices — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
ZOMDF
Zomedica Corp.
this stock
$84.28M -15.7% +17.4% — 0.0%
ABT
Abbott Laboratories
 $203.22B -6.9% +5.7% 32.7 1.3%
SYK
Stryker Corp
 $125.74B -6.7% +11.2% 34.0 2.2%
MDT
Medtronic plc
 $119.56B -3.3% +8.4% 25.0 1.4%
BSX
Boston Scientific Corp
 $73.00B -48.6% +12.5% 20.4 1.5%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
6
% held
0.0%
Net QoQ
-935.3K sh
Top holder
CoreCap Advisors, LLC
Held Float
View
Held by Funds
Fund positions
1
View
Short & Settlement
Short Interest Rising
Shares short
174.4K
Days to cover
1.0d
Change
+46.9K sh
View
Short Volume
Short vol %
16%
As of
Aug 24, 2026
Short Total
View
Fails to Deliver
FTD shares
500
Value
$45
As of
Jul 24, 2026
View
Off-Exchange
Off-exchange %
99.9%
Week of
Jul 20, 2026
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$32.0M
Net income (FY)
$-81.9M
EPS diluted
$-0.08
View
Filings
SEC Filings
Latest
8-K
Filed
Aug 5, 2026
This year
9
View
Exempt Offerings
Offering
Indefinite
Filed
Feb 14, 2020
View
Earnings & Events
Earnings Calls
Last call
Aug 5, 2026
View
Investor Relations
Upcoming events
2
View

Performance

5D 20D 120D MTD YTD
ZOMDF +4.9% -3.3% -28.9% -4.4% -15.7%
SPY -1.2% +3.3% +12.2% +2.2% +12.0%
vs SPY +6.1% -6.6% -41.2% -6.6% -27.7%
Key facts CIK 1684144 CUSIP 98980M109 13F (30d) 2 filings 2 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)